FDA 483 - Gilead Sciences, Inc. - July 17, 2018

Gilead Sciences, Inc. in Foster City, CA, was inspected regarding its drug safety and public health practices. The inspection revealed a significant failure to report serious and unexpected adverse drug experiences to the FDA within the required 15 calendar days. This indicates a lapse in pharmacovigilance and regulatory compliance.